HOUSTON (AP) — Houston Texans defensive end Will Anderson said giving up 36 points in a season-opening loss to the Bills wasn’t a reason to get mad but instead should be a catalyst to improve. “That’s ...
(CNN) — Defense Secretary Pete Hegseth and political appointees in his department pushed for the two crew members of an F-15 who were shot down over Iran in April to participate in Sunday’s highly ...
El presidente Daniel Noboa posteó en sus redes sociales un video en el que presenta la nueva aplicación Data 593, con la que el Gobierno busca que los ciudadanos dejen de cargar carpetas de documentos ...
新华社布鲁塞尔9月5日电18岁的中国选手严子怡5日在2026年世界田联钻石联赛总决赛女子标枪比赛中后来居上，以68米42夺冠，首次捧起钻石联赛年度总冠军奖杯。至此，参加本届总决赛的两名中国 ...
This series of lessons covers the topic of attachment for AQA a Level psychology. This is a complete set of lessons for teaching the new 2027 specification. It includes plenaries extensions some ...
El Gobierno presentó Data 593, una nueva plataforma digital que busca concentrar en una sola aplicación información y servicios de distintas instituciones públicas. La herramienta fue presentada la ...
元DeNA監督の中畑清氏が30日、TBS系「サンデーモーニング」（日曜・午前8時）に生出演した。 【写真】中畑氏＆落合博満氏と集合ショット番組では、ドジャース・大谷翔平投手 ...
Yes in God’s Backyard: More Than 800,000 Homes Could Be Built on Land Owned by Churches—Here’s How Some Are Breaking Ground on Affordable Housing Additional Information About 8221 53rd Ave W Unit 15C, ...
MetroLoft, the developer behind the Manhattan high rise that suddenly buckled on Tuesday, is facing a $350 million-plus lawsuit at star-studded 443 Greenwich St., home to names including Rebel Wilson, ...
A phase 1, multicenter, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of SBO-154 in subjects with advanced solid ...
SEATTLE and SINGAPORE, April 15, 2026 (GLOBE NEWSWIRE)-- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach ...
SEATTLE and SINGAPORE, March 24, 2026 (GLOBE NEWSWIRE)-- Callio Therapeutics, a biotherapeutics company advancing dual-payload antibody-drug conjugates (ADCs) with a targeted, multi-mechanism approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results